DC Devices Lands $34,000,000 Series D Financing Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1db64827-85d4-42fc-863f-865b4aa8ea85
Date 7/1/2014
Company Name DC Devices
Mailing Address 1 Highwood Drive Tewksbury, MA 01876 USA
Company Description DC Devices is developing the first trans-catheter device for diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). The company’s proprietary and innovative IASD (Inter-Atrial Shunt Device) system is minimally invasive and is designed to relieve increased left atrial pressure (LAp), the main cause of DHF/HFpEF symptoms.
Proceeds Purposes Funds will be used to complete clinical evaluation of the world’s first transcatheter device for the treatment of diastolic heart failure (DHF), a $5 billion global market opportunity.